Frequencies for first 10,000 rows of drug7cl1 variable in nhamcsed2004 dataset : drug class #1 for medication #7 | Freq. Percent Cum. ----------------------------------------+----------------------------------- anesthetics, local (injectable) | 4 0.04 0.04 adjuncts to anesthesia/analeptics | 7 0.07 0.11 anesthetics, rectal | 1 0.01 0.12 penicillins | 7 0.07 0.19 cephalosporins | 5 0.05 0.24 erythromycins/lincosamides/macrolides | 14 0.14 0.38 tetracyclines | 2 0.02 0.40 aminoglycosides | 1 0.01 0.41 sulfonamides and trimethoprim | 3 0.03 0.44 quinolones/derivatives | 6 0.06 0.50 antifungals | 1 0.01 0.51 antiviral agents | 2 0.02 0.53 deficiency anemias | 5 0.05 0.58 anticoagulants/thrombolytics | 23 0.23 0.81 cardiac glycosides | 4 0.04 0.85 antiarrhythmic agents | 4 0.04 0.89 antianginal agents | 9 0.09 0.98 antihypertensive agents | 16 0.16 1.14 diuretics | 17 0.17 1.31 coronary vasodilators | 2 0.02 1.33 relaxants/stimulants, urinary tract | 4 0.04 1.37 calcium channel blockers | 5 0.05 1.42 beta blockers | 5 0.05 1.47 alpha agonist/alpha blockers | 6 0.06 1.53 ace inhibitors | 13 0.13 1.66 sedatives and hypnotics | 13 0.13 1.79 antianxiety agents | 11 0.11 1.90 antipsychotic/antimanics | 3 0.03 1.93 antidepressants | 20 0.20 2.13 cns, miscellaneous | 1 0.01 2.14 alzheimer-type dementia | 1 0.01 2.15 disorders, acid/peptic | 27 0.27 2.42 antidiarrheals | 3 0.03 2.45 laxatives | 16 0.16 2.61 miscellaneous gastrointestinals | 1 0.01 2.62 antispasmodics/anticholinergics | 3 0.03 2.65 antacids | 3 0.03 2.68 hyperlipidemia | 15 0.15 2.83 vitamins/minerals | 9 0.09 2.92 nutrition, enteral/parenteral | 1 0.01 2.93 repl/regs of electrolytes/water balance | 17 0.17 3.10 calcium metabolism | 2 0.02 3.12 hematopoietic growth factor | 1 0.01 3.13 adrenal corticosteroids | 7 0.07 3.20 estrogens/progestins | 1 0.01 3.21 blood glucose regulators | 19 0.19 3.40 thyroid/antithyroid | 5 0.05 3.45 vaccines/antisera | 6 0.06 3.51 skin/mucous membrane, unspecified | 1 0.01 3.52 dermatologics, misc. | 1 0.01 3.53 topical anti-infectives | 1 0.01 3.54 extrapyramidal movement disorders | 2 0.02 3.56 skeletal muscle hyperactivity | 2 0.02 3.58 anticonvulsants | 10 0.10 3.68 antineoplastics, miscellaneous | 2 0.02 3.70 ocular anti-infective/anti-inflammatory | 5 0.05 3.75 vertigo/motion sickness/vomiting | 3 0.03 3.78 analgesics, narcotic | 28 0.28 4.06 analgesics, non-narcotic | 26 0.26 4.32 antimigraine/other headaches | 2 0.02 4.34 antiarthritics | 10 0.10 4.44 nsaid | 16 0.16 4.60 antiprotozoals | 3 0.03 4.63 antimalarials | 2 0.02 4.65 antiasthmatics/bronchodilators | 22 0.22 4.87 nasal decongestants | 2 0.02 4.89 antitussives/expectorants/mucolytics | 3 0.03 4.92 antihistamines | 6 0.06 4.98 corticosteroid-inhalation/nasal | 4 0.04 5.02 miscellaneous/unclassified | 2 0.02 5.04 unclassified | 6 0.06 5.10 . | 9,490 94.90 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 28 Mar 2016